Aristolochic Acid and Immunotherapy for Urothelial Carcinoma: Directions for unmet Needs.

Yang, Huang-Yu; Yang, Chih-Chao; Wu, Chao-Yi; Wang, Li-Jen; Lu, Kun-Lin

Yang, Huang-Yu; Yang, Chih-Chao; Wu, Chao-Yi; Wang, Li-Jen; Lu, Kun-Lin.

Afiliación

Yang HY; Department of Nephrology, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan. hyyang01@gmail.com.
Yang CC; Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.
Wu CY; Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
Wang LJ; Department of Medical Imaging and Radiological Science, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
Lu KL; Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital at Linkou, Taoyuan 333, Taiwan.

Int J Mol Sci ; 20(13)2019 Jun 28.

Article en En | MEDLINE | ID: mdl-31261684

Asunto(s)

Ácidos Aristolóquicos/toxicidad; Carcinógenos/toxicidad; Carcinoma/terapia; Inmunoterapia/métodos; Neoplasias de la Vejiga Urinaria/terapia; Animales; Carcinoma/etiología; Humanos; Neoplasias de la Vejiga Urinaria/etiología; Urotelio/efectos de los fármacos; Urotelio/metabolismo; Urotelio/patología

Palabras clave

aristolochic acid; immune checkpoint inhibitors; mutation load; upper tract urothelial carcinoma; urothelial carcinoma of the bladder

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinógenos / Carcinoma / Ácidos Aristolóquicos / Inmunoterapia Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Int J Mol Sci Año: 2019 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google